Meeting Programme

Dr Christine Faulkner (Oxford Brookes University)

Dr Santanu Datta (Cellworks)

Dr Ashwani Pareek (JNU, New Delhi)

Prof A S Raghavendra (University of Hyderabad)

Dr Anu Raghunathan (National Chemical Laboratory, Pune)

Prof David Fell (Oxford Brookes University)

Prof K V Venkatesh (Dept Chemical Engineering, IIT Bombay) (with Pramod Somvanshi and Anil Pate)

Multi-scale Structured Kinetic Model for Analyzing Disease States in Metabolic Syndrome

Metabolic syndrome is among the most complex diseases with multiple complications associated with it such as insulin resistance, central obesity, Type 2 diabetes, hypercholesterolemia, hypertension, atherosclerosis and coronary artery disease. It has been found that these are system level diseases with defects at metabolic, signaling and genetic levels rather than defects in individual biological entities. In metabolic syndrome, insulin resistance is the key defects which affect various metabolic processes. Defects in insulin secretion, its activity, and its signaling generate insulin resistance. Insulin signaling pathway orchestrates its response with various other pathways coupled with feedback mechanisms to generate multiple effects. Moreover various other hormones and inflammatory pathways are known to modulate the insulin activity. Insulin resistance is thus a combinatorial effect of all these factors.

The systems biological approach with mathematical modeling of the biological networks serves as an important way to assess these diseases. We attempt to integrate the models of meal simulation, whole body metabolism, insulin signaling pathway and insulin secretion which scale from cellular to organ levels. We assort to the kinetic modeling and analysis of the integrated network and analyze the metabolic response with respect to perturbation in various parameters of the model. The detailed integrated network of various affected metabolic, signaling and genetic pathways is prepared. The kinetic models are developed that describe various interactions. Parameter values and other constants are collected from the literature and are also estimated through optimization and curve fitting for the model. The models are then simulated for sensitivity and phase-plane analysis to notice the key parameters that have major influence on the overall network behavior. Furthermore, Perturbation analysis is performed to get the matrix of parameters for healthy and disease phenotype. Such an analysis helps in understanding the system dynamics and help in answering various ‘What-if’ kinds of questions that can aid in identification of potential drug targets and design effective therapies. We further extend the analysis to address the link between metabolism and tumor genesis by extending the above model by integrating P53 pathway to AKT-PTEN and further representing the regulation of metabolism through HIF1 activity. Analysis shows that the perturbation at AKT node can affect metabolism leading to tumor genesis demonstrating Warburg Effect. Thus the model for the whole-body metabolism including signaling pathways can yield insights into the emergence of disease states.